vTv Therapeutics (VTVT) Short Interest Ratio & Short Volume $14.30 -0.19 (-1.31%) Closing price 08/13/2025 03:53 PM EasternExtended Trading$14.30 0.00 (0.00%) As of 08/13/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock vTv Therapeutics Short Interest DatavTv Therapeutics (VTVT) has a short interest of 14,600 shares, representing 0.98% of the float (the number of shares available for trading by the public). This marks a -99.10% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.1, indicating that it would take 2.1 days of the average trading volume of 1,198 shares to cover all short positions.Current Short Interest14,600 sharesPrevious Short Interest1,630,000 sharesChange Vs. Previous Month-99.10%Dollar Volume Sold Short$246.45 thousandShort Interest Ratio2.1 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares3,190,000 sharesFloat Size1,490,000 sharesShort Percent of Float0.98%Today's Trading Volume1,612 sharesAverage Trading Volume1,198 sharesToday's Volume Vs. Average135% Short Selling vTv Therapeutics? Sign up to receive the latest short interest report for vTv Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVTVT Short Interest Over TimeVTVT Days to Cover Over TimeVTVT Percentage of Float Shorted Over Time vTv Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/202514,600 shares $246.45 thousand -99.1%1.0%2.1 $16.88 6/30/20251,630,000 shares $24.45 million +8,955.6%53.3%0.6 $15.00 6/15/202518,000 shares $278.28 thousand -3.7%1.2%2.4 $15.46 5/31/202518,700 shares $295.29 thousand +14.0%1.3%1 $15.79 5/15/202516,400 shares $367.52 thousand -24.1%1.1%0.8 $22.41 4/30/202521,600 shares $430.92 thousand -5.7%1.5%1 $19.95 4/15/202522,900 shares $425.48 thousand +42.2%1.6%1 $18.58 3/31/202516,100 shares $278.85 thousand -34.3%1.1%0.7 $17.32 3/15/202524,500 shares $363.83 thousand +1.7%1.7%1.1 $14.85 2/28/202524,100 shares $473.81 thousand -13.6%1.6%1.8 $19.66 Get the Latest News and Ratings for VTVT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for vTv Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/202527,900 shares $605.43 thousand +4.5%1.9%1.8 $21.70 1/31/202526,700 shares $417.05 thousand +18.7%1.8%1.1 $15.62 1/15/202522,500 shares $316.13 thousand +33.1%1.5%0.8 $14.05 12/31/202416,900 shares $233.39 thousand No Change1.1%0.6 $13.81 12/15/202416,900 shares $254.01 thousand -24.9%1.1%0.6 $15.03 11/30/202422,500 shares $360.90 thousand -17.3%1.6%0.7 $16.04 11/15/202427,200 shares $469.20 thousand -5.9%1.9%0.9 $17.25 10/31/202428,900 shares $396.51 thousand -0.3%2.2%1 $13.72 10/15/202429,000 shares $386.86 thousand -7.9%2.3%1 $13.34 9/30/202431,500 shares $424.62 thousand +1.6%2.4%1.1 $13.48 9/15/202431,000 shares $442.06 thousand -6.3%2.4%1 $14.26 8/31/202433,100 shares $520.00 thousand -13.1%2.6%1.2 $15.71 8/15/202438,100 shares $513.97 thousand +34.6%3.0%1.5 $13.49 7/31/202428,300 shares $429.03 thousand +45.9%2.2%1.4 $15.16 7/15/202419,400 shares $473.17 thousand -1.0%1.5%1.6 $24.39 6/30/202419,600 shares $346.14 thousand -10.5%1.5%2.6 $17.66 6/15/202421,900 shares $460.34 thousand +17.7%1.7%3.4 $21.02 5/31/202418,600 shares $433.94 thousand -21.9%1.4%1.8 $23.33 5/15/202423,800 shares $615.94 thousand -10.5%1.8%0.4 $25.88 4/30/202426,600 shares $742.14 thousand -7.6%3.2%0.4 $27.90 4/15/202428,800 shares $720 thousand -10.6%3.4%0.4 $25.00 3/31/202432,200 shares $757.67 thousand -43.7%6.1%0.4 $23.53 3/15/202457,200 shares $1.03 million +50.5%10.9%0.8 $18.00 2/29/202438,000 shares $666.90 thousand -12.0%8.4%0.5 $17.55 2/15/202443,200 shares $415.15 thousand -39.1%6.5%1.4 $9.61 1/31/202470,900 shares $596.27 thousand +78.6%10.7%2.2 $8.41 1/15/202439,700 shares $363.26 thousand -20.8%6.0%1.5 $9.15 12/31/202350,100 shares $576.15 thousand +27.8%N/A2.3 $11.50 12/15/202339,200 shares $343 thousand +10.4%5.9%2 $8.75 11/30/202335,500 shares $507.30 thousand +25.0%5.3%2.1 $14.29Generate up to $5,000/month with 10X less money? (Ad)The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly income to cover housing, healthcare, food, and fun... With a fraction of what you probably think you need.Here's the secret to retiring without a million-dollar nest egg → 11/15/202328,400 shares $398.74 thousand -97.6%4.3%7.7 $14.04 10/31/20231,180,000 shares $484.98 thousand -6.4%4.4%7.1 $0.41 10/15/20231,260,000 shares $587.29 thousand +4.1%4.7%7.1 $0.47 9/30/20231,210,000 shares $578.38 thousand -4.0%4.5%6.7 $0.48 9/15/20231,260,000 shares $560.83 thousand +4.1%4.6%7.6 $0.45 8/31/20231,210,000 shares $617.10 thousand -13.6%4.4%5.8 $0.51 8/15/20231,400,000 shares $998.76 thousand +15.7%5.1%6.2 $0.71 7/31/20231,210,000 shares $817.96 thousand -4.7%4.4%8.5 $0.68 7/15/20231,270,000 shares $915.67 thousand -1.6%4.6%9.8 $0.72 6/30/20231,290,000 shares $954.34 thousand +7.5%4.7%10.2 $0.74 6/15/20231,200,000 shares $911.88 thousand -3.2%4.4%9.6 $0.76 5/31/20231,240,000 shares $979.60 thousand +6.9%4.5%15.1 $0.79 5/15/20231,160,000 shares $996.21 thousand -1.7%4.2%12.6 $0.86 4/30/20231,180,000 shares $908.60 thousand -0.8%4.3%13.4 $0.77 4/15/20231,190,000 shares $880.84 thousand -0.8%4.4%13.6 $0.74 3/31/20231,200,000 shares $969.36 thousand -1.6%4.4%12.2 $0.81 3/15/20231,220,000 shares $964.04 thousand +8.9%4.5%11.5 $0.79 2/28/20231,120,000 shares $907.20 thousand No Change4.1%10.3 $0.81 2/15/20231,120,000 shares $985.60 thousand -4.3%4.1%17.3 $0.88 1/31/20231,170,000 shares $1.11 million +3.5%4.3%16.6 $0.95 1/15/20231,130,000 shares $921.97 thousand -4.2%4.1%16.4 $0.82 12/30/20221,180,000 shares $782.10 thousand +8.3%4.3%17.9 $0.66 12/15/20221,090,000 shares $775.97 thousand +2.8%4.0%18.1 $0.71 11/30/20221,060,000 shares $873.86 thousand -1.9%3.9%15.5 $0.82 11/15/20221,080,000 shares $950.51 thousand -3.6%4.0%15.2 $0.88 10/31/20221,120,000 shares $967.68 thousand No Change4.1%10.2 $0.86 10/15/20221,120,000 shares $958.05 thousand -8.2%4.1%6.3 $0.86 9/30/20221,220,000 shares $1.18 million -0.8%4.5%5.3 $0.97 9/15/20221,230,000 shares $1.41 million -3.2%4.5%5 $1.15 8/31/20221,270,000 shares $1.35 million -5.9%8.1%4.4 $1.06 8/15/20221,350,000 shares $1.85 million -19.2%6.1%1.5 $1.37 7/31/20221,670,000 shares $1.50 million +21.9%9.2%1.8 $0.90 7/15/20221,370,000 shares $934.34 thousand -9.3%7.5%1.6 $0.68 6/30/20221,510,000 shares $1.13 million -15.2%8.3%1.8 $0.75 6/15/20221,780,000 shares $1.34 million +17.1%9.8%2.1 $0.76 5/31/20221,520,000 shares $837.52 thousand -13.1%5.3%1.8 $0.55 5/15/20221,750,000 shares $743.75 thousand No Change6.1%6.7 $0.43 4/30/20221,750,000 shares $1.21 million -0.6%6.1%7.5 $0.69 4/15/20221,760,000 shares $1.39 million +1.2%6.1%7.3 $0.79 3/31/20221,740,000 shares $1.26 million +3.6%6.1%6.9 $0.72 3/15/20221,680,000 shares $924.84 thousand -13.0%5.9%5.7 $0.55 2/28/20221,930,000 shares $1.58 million +19.1%6.7%6.2 $0.82 2/15/20221,620,000 shares $1.20 million -0.6%5.7%5.1 $0.74 1/31/20221,630,000 shares $1.17 million +1.2%5.4%4.4 $0.72 1/15/20221,610,000 shares $1.42 million -5.3%5.3%3.5 $0.88 12/31/20211,700,000 shares $1.69 million -6.1%N/A2.8 $1.00 12/15/20211,810,000 shares $2.03 million -13.4%6.0%1.1 $1.12 11/30/20212,090,000 shares $2.59 million -2.3%8.0%1.1 $1.24 11/15/20212,140,000 shares $3.32 million +9.2%8.2%1.2 $1.55 10/29/20211,960,000 shares $2.80 million -22.8%8.4%1.1 $1.43Tesla is in trouble (Ad)This company is the lifeblood of AI data centers, yet almost no one has caught up with the story. Their hardware is so essential that the data center industry uses enough of it to stretch around the world 8 times – in a single building! So, if you own Nvidia stock now, you might be well-served to sell those shares and check out this under-the-radar play instead. Or if you missed the boat on Nvidia, this is a rare second chance to target tremendous profit potential as AI data centers spring up in every corner of the world.Get my full take on this exciting play right here… 10/15/20212,540,000 shares $3.73 million +15.5%10.8%1.5 $1.47 9/30/20212,200,000 shares $3.37 million +39.2%9.4%1.4 $1.53 9/15/20211,580,000 shares $2.73 million -8.7%6.7%1.1 $1.73 8/31/20211,730,000 shares $3.24 million -14.4%7.4%1.6 $1.87 8/13/20212,020,000 shares $3.72 million -4.3%8.6%1.6 $1.84 7/30/20212,110,000 shares $4.05 million +2.9%9.0%1.4 $1.92 7/15/20212,050,000 shares $4.12 million -10.1%8.7%1.3 $2.01 6/30/20212,280,000 shares $5.20 million -5.4%10.3%0.4 $2.28 6/15/20212,410,000 shares $6.17 million +5.7%10.9%0.4 $2.56 5/28/20212,280,000 shares $5.61 million -11.3%10.7%0.4 $2.46 5/14/20212,570,000 shares $5.83 million -17.4%12.2%0.5 $2.27 4/30/20213,110,000 shares $8.21 million -39.9%14.8%0.5 $2.64 4/15/20215,170,000 shares $17.22 million +138.3%24.8%0.7 $3.33 3/31/20212,170,000 shares $5.82 million -4.4%10.4%0.7 $2.68 3/15/20212,270,000 shares $6.13 million -9.9%11.0%0.7 $2.70 2/26/20212,520,000 shares $6.40 million -17.7%15.9%0.5 $2.54 2/12/20213,060,000 shares $8.26 million -7.0%21.8%0.6 $2.70 1/29/20213,290,000 shares $6.58 million +12.3%25.4%0.7 $2.00 1/15/20212,930,000 shares $6.30 million +5.0%22.6%0.9 $2.15 12/31/20202,790,000 shares $5.38 million -26.8%21.5%1 $1.93 12/15/20203,810,000 shares $11.32 million +73.2%29.4%1.4 $2.97 11/30/20202,200,000 shares $4.73 million +5.3%18.2%3.4 $2.15 10/30/20201,940,000 shares $3.38 million -2.0%15.3%3.9 $1.74 10/15/20201,980,000 shares $3.45 million -1.0%16.5%4.2 $1.74 9/30/20202,000,000 shares $3.54 million +0.5%16.7%4.1 $1.77 9/15/20201,990,000 shares $3.88 million +4.7%16.6%3.8 $1.95 8/31/20201,900,000 shares $3.95 million +8.6%15.8%3.4 $2.08 8/14/20201,750,000 shares $4.25 million -0.6%18.7%2.9 $2.43 VTVT Short Interest - Frequently Asked Questions What is vTv Therapeutics' current short interest? Short interest is the volume of vTv Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 14,600 shares of VTVT short. 0.98% of vTv Therapeutics' shares are currently sold short. Learn More on vTv Therapeutics' current short interest. What is a good short interest ratio for vTv Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VTVT shares currently have a short interest ratio of 2.0. Learn More on vTv Therapeutics's short interest ratio. What is a good short interest percentage for vTv Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.98% of vTv Therapeutics' floating shares are currently sold short. Is vTv Therapeutics' short interest increasing or decreasing? vTv Therapeutics saw a decline in short interest during the month of July. As of July 15th, there was short interest totaling 14,600 shares, a decline of 99.1% from the previous total of 1,630,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is vTv Therapeutics' float size? vTv Therapeutics currently has issued a total of 3,190,000 shares. Some of vTv Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. vTv Therapeutics currently has a public float of 1,490,000 shares. How does vTv Therapeutics' short interest compare to its competitors? 0.98% of vTv Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to vTv Therapeutics: Semper Paratus Acquisition Corporation (4.57%), Caribou Biosciences, Inc. (5.71%), Organigram Global Inc. (6.19%), DiaMedica Therapeutics, Inc. (4.66%), Cardiff Oncology, Inc. (28.41%), Rapt Therapeutics (5.67%), Lyell Immunopharma, Inc. (3.59%), Aclaris Therapeutics, Inc. (7.18%), SELLAS Life Sciences Group, Inc. (27.80%), Cellectis S.A. (0.47%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short vTv Therapeutics stock? Short selling VTVT is an investing strategy that aims to generate trading profit from vTv Therapeutics as its price is falling. VTVT shares are trading down $0.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against vTv Therapeutics? A short squeeze for vTv Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VTVT, which in turn drives the price of the stock up even further. How often is vTv Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VTVT, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies Semper Paratus Acquisition Short Interest Caribou Biosciences Short Interest Organigram Global Short Interest DiaMedica Therapeutics Short Interest Cardiff Oncology Short Interest Rapt Therapeutics Short Interest Lyell Immunopharma Short Interest Aclaris Therapeutics Short Interest SELLAS Life Sciences Group Short Interest Cellectis Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VTVT) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGet This Stock NowThis company is the lifeblood of AI data centers, yet almost no one has caught up with the story. Their hardwa...InvestorPlace | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredD.C.’s secret plan to crush the debt.At a recent gathering with some of the most powerful people in America, Jeff discovered the Trump administrati...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding vTv Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share vTv Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access